14 terminated, 1 completed. 11 Phase 3, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 11 | Terminated 11 |
| Phase 2 | 4 | Terminated 3, Completed 1 |
Follow tesaglitazar: new trials by email Literature Review of tesaglitazar trials Research Report on tesaglitazar
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GALLEX 4 - Long-Term Extension Study to Evaluate Tesaglitazar Therapy in Patients With Type 2 Diabetes Tesaglitazar - Type 2 Diabetes | Phase 3 | Terminated | AstraZeneca | 400 | 2005-10-01 | 2008-03-17 |
| ARAMIS: Actions of tesaglitazaR on fAt Metabolism and Insulin Sensitivity Tesaglitazar, Metformin, Dietary and lifestyle modification counseling - Type 2 Diabetes | Phase 2 | Terminated | AstraZeneca | 105 | 2005-08-01 | 2008-03-17 |
| GALLANT 22 Tesaglitazar vs. Placebo Tesaglitazar, Dietary and Lifestyle counseling - Type 2 Diabetes | Phase 3 | Terminated | AstraZeneca | 475 | 2005-04-01 | 2008-03-17 |
| GALLEX 1 - Long Term Extension Study in Patients With Type 2 Diabetes tesaglitazar - Type 2 Diabetes | Phase 3 | Terminated | AstraZeneca | 2000 | 2005-03-01 | 2008-03-17 |
| GALLANT 14 Tesaglitazar vs. Metformin and Fenofibrate Tesaglitazar, Metformin, Fenofibrate - Type 2 Diabetes | Phase 3 | Terminated | AstraZeneca | 1000 | 2005-03-01 | 2009-04-22 |
| GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes Mellitus Tesaglitazar, Pioglitazone - Diabetes Mellitus, Type 2 | Phase 3 | Terminated | AstraZeneca | 1100 | 2005-03-01 | 2010-11-19 |
| GALLEX 9: Safety and Tolerability of Oral Tesaglitazar When Added to Insulin Therapy in Patients With Type 2 Diabetes Tesaglitazar - Diabetes Mellitus, Type 2 | Phase 3 | Terminated | AstraZeneca | 270 | 2005-02-01 | 2010-11-19 |
| GALLANT 2 Tesaglitazar vs. Placebo Tesaglitazar, Dietary and Lifestyle counseling - Type 2 Diabetes | Phase 3 | Terminated | AstraZeneca | 80 | 2004-09-01 | 2009-04-22 |
| GALLANT 4 Tesaglitazar vs. Glibenclamide Tesaglitazar, Glibenclamide - Type 2 Diabetes | Phase 3 | Terminated | AstraZeneca | 580 | 2004-09-01 | 2008-03-17 |
| ARMOR (Analyzing Renal Mechanisms of Creatinine Excretion in Patients On tesaglitazaR) Tesaglitazar, pioglitazone - Diabetes Mellitus, Type 2 | Phase 2 | Terminated | AstraZeneca | 100 | 2004-09-01 | 2011-08-30 |
| GALLANT 6 Tesaglitazar vs. Pioglitazone Galida - Diabetes Mellitus, Type 2 | Phase 3 | Terminated | AstraZeneca | 1450 | 2004-08-01 | 2010-11-19 |
| GALLANT 5 Tesaglitazar Versus Metformin GALIDA - Diabetes Mellitus, Type 2 | Phase 3 | Terminated | AstraZeneca | 580 | 2004-08-01 | 2010-11-19 |
| GALLANT 8 Tesaglitazar Add-on to Metformin Tesaglitazar, Metformin - Type 2 Diabetes | Phase 3 | Terminated | AstraZeneca | 555 | 2004-07-01 | 2009-04-22 |
| Dose Response Study in Japanese Patients Tesaglitazar - Type 2 Diabetes | Phase 2 | Terminated | AstraZeneca | 250 | 2004-05-01 | 2009-04-22 |
| GLAD: Dose-Finding, Efficacy, and Safety of AZ 242 (Tesaglitazar) in Subjects With Type 2 Diabetes Tesaglitazar, Pioglitazone, Dietary and Lifestyle Modification Counseling - Type 2 Diabetes | Phase 2 | Completed | AstraZeneca | 500 | 2002-04-01 | 2006-07-31 |
Diabetes Mellitus, Type 2 (15)
AstraZeneca (15)
Finland (8) · United States (7) · Canada (6) · Philippines (6) · United Kingdom (6) · Hungary (5) · Italy (5) · Malaysia (5) · Norway (5) · Brazil (4) · Hong Kong (4) · Mexico (4) · Poland (4) · Slovakia (4) · South Africa (4)